Clinical trial
Comparison of Emergence/Dysphoric Reaction Frequency of Using Ketamine at 2 Different Doses in Interventional Sedation and Analgesia
Name
cagriturkucu
Description
The aim of this study is to compare the effect of using different doses of ketamine on producing dysphoric reaction.
Trial arms
Trial start
2023-01-01
Estimated PCD
2023-09-15
Trial end
2023-12-31
Status
Active (not recruiting)
Treatment
Ketalar 50 MG/ML Injectable Solution
Ketamine will be administered to two different groups as 0.5 mg/kg and 1 mg/kg
Arms:
The group given 0.5 mg/kg ketamine, The group given 1 mg/kg ketamine
Other names:
ketamine hydrochloride
Size
108
Primary endpoint
To observe a significant difference between the two doses in terms of producing a dysphoric reaction
January 2023-August 2023
Eligibility criteria
Inclusion Criteria:
* Glaskow coma scale should be 15
* Inability to speak, read or understand English or Turkish
* Patients needing procedural sedation and analgesia
Exclusion Criteria:
* Patients with active coronary artery disease
* Patients with liver or kidney transplant
* Patients with conditions that change consciousness such as substance intake, alcohol intake
* Patients with advanced COPD or Heart failure
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'OTHER', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 108, 'type': 'ESTIMATED'}}
Updated at
2023-12-18
1 organization
1 product
1 indication
Product
KetalarIndication
Sedation Complication